These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12109492)

  • 21. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bridging therapy in acute ischemic stroke: a systematic review and meta-analysis.
    Mazighi M; Meseguer E; Labreuche J; Amarenco P
    Stroke; 2012 May; 43(5):1302-8. PubMed ID: 22529310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.
    IMS Study Investigators
    Stroke; 2004 Apr; 35(4):904-11. PubMed ID: 15017018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():641-6. PubMed ID: 12735044
    [No Abstract]   [Full Text] [Related]  

  • 25. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guidelines for intravenous thrombolytic therapy in acute ischemic stroke with special reference to those by the Ad Hoc Committee of the Japan Stroke Society].
    Minematsu K
    No To Shinkei; 2006 Nov; 58(11):915-21. PubMed ID: 17133996
    [No Abstract]   [Full Text] [Related]  

  • 27. Is acute stroke treatment heading towards a more endovascular approach?
    Menon BK; Demchuk AM
    Lancet Neurol; 2009 Sep; 8(9):778-9. PubMed ID: 19647487
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.
    Shobha N; Buchan AM; Hill MD;
    Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised trials of endovascular treatment of stroke are needed.
    Ciccone A; Sterzi R
    Lancet Neurol; 2010 Jan; 9(1):30; author reply 31-2. PubMed ID: 20083033
    [No Abstract]   [Full Text] [Related]  

  • 30. Bolus-to-Infusion Time in Stroke Patients Treated with Alteplase on the CT Table: A Clinical Concern.
    Iglesias Mohedano AM; García Pastor A; de Lorenzo Pinto A; Gil Núñez AC
    Cerebrovasc Dis; 2019; 48(1-2):96-98. PubMed ID: 31593952
    [No Abstract]   [Full Text] [Related]  

  • 31. Adding to the effectiveness of intravenous tissue plasminogen activator for treating acute stroke.
    Grotta JC
    Circulation; 2003 Jun; 107(22):2769-70. PubMed ID: 12796412
    [No Abstract]   [Full Text] [Related]  

  • 32. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous thrombolytic therapy for acute ischemic stroke.
    Wechsler LR
    N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute Thrombocytopenia After Tissue Plasminogen Activator for Stroke.
    Morena J; May C; Strohm T
    J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104865. PubMed ID: 32404288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute stroke endovascular treatment: tips and tricks.
    Rangel-Castilla L; Rajah GB; Shakir HJ; Davies JM; Snyder KV; Siddiqui AH; Levy EI; Hopkins LN
    J Cardiovasc Surg (Torino); 2016 Dec; 57(6):758-768. PubMed ID: 27654099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome.
    Machumpurath B; Davis SM; Yan B
    Cerebrovasc Dis; 2011; 31(3):278-83. PubMed ID: 21178353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. tPA in daily clinical practice.
    Nighoghossian N
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12733503
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke.
    Shah SH; Liebeskind DS; Saver JL; Starkman S; Vinuela F; Duckwiler G; Jahan R; Kim D; Sanossian N; Vespa P; Ovbiagele B
    Neurology; 2006 Jun; 66(11):1745-6. PubMed ID: 16769954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
    Marder VJ
    Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.